BioMarin Pharma (BMRN) Tops Q1 EPS by 43c
Tweet
Share
E-mail
Get Alerts BMRN Hot Sheet
Price: $65.08 --0%
EPS Growth %: +1,016.7%
Financial Fact:
Intangible asset amortization and contingent consideration: 9.65M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +1,016.7%
Financial Fact:
Intangible asset amortization and contingent consideration: 9.65M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
BioMarin Pharma (NASDAQ: BMRN) reported Q1 EPS of $1.13, $0.43 better than the analyst estimate of $0.70. Revenue for the quarter came in at $745 million versus the consensus estimate of $741.02 million.
For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Philip Morris (PM) Reiterated at Buy by Stifel - 'Bullish on Growth Prospects'
- Mercado Minerals Signs LOI to Acquire La Franca within the Zamora Project and Samples 1.00 Metre of 1.53 kg/t Silver and 1.39 g/t Gold
- Stephens Starts Mechanics Bancorp (MCHB) at Equal Weight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
